Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
NJ Bio Expands Its State-Of-The-Art Facility in Princeton, New Jersey
Friday, December 03, 2021NJ Biopharmaceuticals LLC an expert provider of chemistry and biopharmaceutical services specializing in bioconjugation custom synthesis flow chemistry and process development has expanded its footprint at its stateoftheart laboratory and headquarter...
Sanofi to acquire Origimm Biotechnology in first move to treat acne with vaccine-based immunotherapy
Thursday, December 02, 2021Sanofi announced today it entered into an agreement to acquire Origimm Biotechnology GmbH an Austrian privately owned biotechnology company specializing in the discovery of virulent skin microbiome components and antigens from bacteria causing skin d...
Astellas and Dyno Therapeutics Announce Research Collaboration to Develop Next-Generation AAV Gene Therapy Vectors for Skeletal and Cardiac Muscle
Thursday, December 02, 2021Astellas Pharma Inc and Dyno Therapeutics Inc announced an option and license agreement was signed on November to develop nextgeneration adenoassociated virus AAV vectors for gene therapy directed to skeletal and cardiac muscle using Dynos CapsidMap...
UCB and Chiesi enter global license agreement for zampilimab a novel monoclonal antibody for fibrotic lung diseases
Wednesday, December 01, 2021UCB a global biopharmaceutical company and Chiesi Group the international researchfocused pharmaceutical and healthcare group are pleased to announce that they have entered into an agreement that grants Chiesi a worldwide exclusive license to develop...
Kymera Therapeutics Announces FDA Clearance of Investigational New Drug Application (IND) for IRAKIMiD Degrader, KT-413
Wednesday, December 01, 2021Kymera Therapeutics Inc a clinicalstage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines today announced the clearance of its Investigational New Drug IND application from the...
Blueprint Medicines to Expand Precision Therapy Leadership in Lung Cancer with Acquisition of Lengo Therapeutics
Tuesday, November 30, 2021Blueprint Medicines Corporation announced that the company has entered into a definitive agreement under which it will acquire Lengo Therapeutics a privately held precision oncology company for million in cash plus up to million in additional poten...
Thermo Fisher Scientific Confirms Detection of SARS-CoV-2 in Samples Containing the Omicron Variant with its TaqPath COVID-19 Tests
Tuesday, November 30, 2021Thermo Fisher Scientific Inc the world leader in serving science today confirmed that its polymerase chain reaction PCR TaqPath COVID Combo Kit and TaqPath COVID CEIVD RTPCR Kit which test for the presence of SARSCoV are not impacted by the emerging...
Amgen and Bushu Pharma Announce Expanded Supply Chain Partnership across Japan and Asia-Pacific Region
Thursday, November 25, 2021Bushu Pharmaceuticals Ltd has agreed on an expanded partnership with Amgen Inc and Amgen KK to provide its Gateway to Asia service to four countries across the AsiaPacific region as Amgens contract manufacturing organization CMO An integral factor in...
GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing
Thursday, November 25, 2021GreenLight Biosciences a biotechnology company dedicated to making ribonucleic acid RNA products affordable and accessible for human health and agriculture and Environmental Impact Acquisition Corp and Samsung Biologics KRX KS a leading global CDMO p...
Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19 Vaccine VLA2001
Wednesday, November 24, 2021Valneva SE a specialty vaccine company today announced that it has signed an Advance Purchase Agreement APA with the European Commission EC to supply up to million doses of its inactivated COVID vaccine candidate VLA over two years The agreement fol...
